SEC 13F Intelligence

Neuberger Berman Group LLC / LLY

Neuberger Berman Group LLC’s Eli Lilly & Co Position

Does Neuberger Berman Group LLC own Eli Lilly & Co (LLY)? Yes — 1.73M shares worth $1.6B (+1.21% of its 13F portfolio) as of Q1 2026, down from 1.78M shares the prior filed quarter.

Position Value
$1.6B
Q1 2026
Shares
1.73M
% of Portfolio
+1.21%
Quarters Held
30
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $157MQ4 ’18Q1 ’19: $157MQ2 ’19: $127MQ3 ’19: $107MQ4 ’19: $123MQ4 ’19Q1 ’20: $135MQ2 ’20: $159MQ3 ’20: $147MQ4 ’20: $161MQ4 ’20Q1 ’21: $165MQ2 ’21: $211MQ3 ’21: $205MQ4 ’21: $355MQ4 ’21Q1 ’22: $381MQ2 ’22: $445MQ3 ’22: $437MQ4 ’22: $487MQ4 ’22Q1 ’23: $483MQ2 ’23: $689MQ3 ’23: $808MQ4 ’23: $844MQ4 ’23Q1 ’24: $1.1BQ2 ’24: $1.3BQ3 ’24: $1.3BQ4 ’24: $1.1BQ4 ’24Q1 ’25: $1.3BQ2 ’25: $1.2BQ3 ’25: $1.3BQ4 ’25: $1.9BQ4 ’25Q1 ’26: $1.6Bfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.73M$1.6B+1.21%
Q4 20251.78M$1.9B+1.42%
Q3 20251.75M$1.3B+0.97%
Q2 20251.56M$1.2B+0.93%
Q1 20251.52M$1.3B+1.05%
Q4 20241.46M$1.1B+0.89%
Q3 20241.44M$1.3B+0.99%
Q2 20241.45M$1.3B+1.08%
Q1 20241.39M$1.1B+0.90%
Q4 20231.45M$844M+0.74%
Q3 20231.50M$808M+0.74%
Q2 20231.47M$689M+0.62%
Q1 20231.41M$483M+0.45%
Q4 20221.33M$487M+0.48%
Q3 20221.35M$437M+0.46%
Q2 20221.37M$445M+0.45%
Q1 20221.33M$381M+0.32%
Q4 20211.30M$355M+0.28%
Q3 2021895.5K$205M+0.18%
Q2 2021925.2K$211M+0.18%
Q1 2021883.8K$165M+0.16%
Q4 2020952.1K$161M+0.17%
Q3 2020995.2K$147M+0.17%
Q2 2020967.9K$159M+0.20%
Q1 2020970.8K$135M+0.21%
Q4 2019938.2K$123M+0.14%
Q3 2019956.3K$107M+0.13%
Q2 20191.15M$127M+0.15%
Q1 20191.21M$157M+0.19%
Q4 20181.36M$157M+0.22%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Neuberger Berman Group LLC’s full portfolio or all institutional holders of LLY.